WallStSmart

Kenvue Inc. (KVUE)vsSolesence, Inc. Common Stock (SLSN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 27727% more annual revenue ($15.41B vs $55.37M). KVUE leads profitability with a 10.8% profit margin vs -5.3%. KVUE earns a higher WallStSmart Score of 60/100 (C).

KVUE

Buy

60

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: 1.22

SLSN

Avoid

20

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 3/9Altman Z: -0.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-86.5%)

Margin of Safety

-86.5%

Fair Value

$9.94

Current Price

$17.78

$7.84 premium

UndervaluedFair: $9.94Overvalued

Intrinsic value data unavailable for SLSN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

SLSN0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

SLSN4 concerns · Avg: 3.0/10
Market CapQuality
$59.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

Operating MarginProfitability
0.8%3/10

Operating margin of 0.8%

Debt/EquityHealth
1.733/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bull Case : SLSN

SLSN has a balanced fundamental profile.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Bear Case : SLSN

The primary concerns for SLSN are Market Cap, Return on Equity, Operating Margin. Debt-to-equity of 1.73 is elevated, increasing financial risk.

Key Dynamics to Monitor

KVUE profiles as a value stock while SLSN is a turnaround play — different risk/reward profiles.

SLSN carries more volatility with a beta of 1.27 — expect wider price swings.

KVUE is growing revenue faster at 3.0% — sustainability is the question.

KVUE generates stronger free cash flow (549M), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (60/100 vs 20/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Solesence, Inc. Common Stock

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company is headquartered in Romeoville, Illinois.

Want to dig deeper into these stocks?